Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Patent
1995-06-07
1998-08-11
Feisee, Lila
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
4241301, 4241411, 5303881, 5303871, 5303873, 5303888, 5303913, 5303917, A61K 39395, C12P 2108
Patent
active
057924562
ABSTRACT:
The present invention provides mutant BR96 polypeptides having a variable region comprising an amino acid sequence derived from the variable region of BR96.
REFERENCES:
patent: 4474893 (1984-10-01), Reading
patent: 4507391 (1985-03-01), Pukel et al.
patent: 4579827 (1986-04-01), Sakamoto et al.
patent: 4612282 (1986-09-01), Schlom et al.
patent: 4676980 (1987-06-01), Segal
patent: 4708930 (1987-11-01), Kortright et al.
patent: 4713351 (1987-12-01), Knauf et al.
patent: 4713352 (1987-12-01), Bander et al.
patent: 4737579 (1988-04-01), Hellstrom et al.
patent: 4753894 (1988-06-01), Frankel et al.
Nisonoff et al., "The Antibody Molecule," Academic Press, New York (1975) (Exhibit 12).
Hellstrom et al., "Antitumor Effects of L6, an IgG2a Antibody that Reacts with Most Human Carcinomas", Proc. Natl. Acad. Sci. USA, 83:7059-7063 (1986) (Exhibit 13).
Drebin et al., "Monoclonal Antibodies Specific for the Neu Oncogene Product Directly Mediate Anti-tumor Effects in Vivo", Oncogene, 2:387-394 (1988) (Exhibit 14).
Papsidero, "Recent Progress in the Immunological Monitoring of Carcinomas Using Monoclonal Antibodies", Semin. Surg. Oncol. 1, 171-81 (1985) (Exhibit 15).
Schlom et al., "Potential Clinical Utility of Monoclonal Antibodies in the Management of Human Carcinomas", Important Adv. Oncol., pp. 170-192 (1985) (Exhibit 16).
Allum et al., "Monoclonal Antibodies in the Diagnosis and Treatment of Malignant Conditions", Surg. Ann. 18 41-64 (1986) (Exhibit 17).
Houghton et al., "Monoclonal Antibodies: Potential Applications to the Treatment of Cancer", Semin. Oncol., 13 (No. 2), pp. 165-179 (1986) (Exhibit 18).
Fink et al., "Monoclonal Antibodies as Diagnostic Reagents for the Identification and Characterization of Human Tumor Antigens", Prog. Clin. Pathol. 9, 121-33 (1984) (Exhibit 19).
Johnston "Applications of Monoclonal Antibodies in Clinical Cytology as Exemplified by Studies with Monoclonal Antibody B72.3", Acta. Cytol. 1, 537-56 (1987) (Exhibit 20).
Young et al., "Production of Monoclonal Antibodies specific for two Distinct Steric Portions of the Glycolipid Anglio-N-Riosylceramide (Asialo GM.sub.2)", J. Exp. Med. 150, 1008-19 (1979) (Exhibit 21).
Kneip et al., "Gangliotriaoslyceramide (Asiolo GM.sub.2) A Glycosphingolipid Marker for Cell Lines Derived from Patients with Hodgkin's Disease", J. Immuniol. 131, 1591-94 (1983) (Exhibit 22).
Rosen et al., "Analysis of Human Small Cell Lung Cancer Differentiation Antigens Using a Panel of Rat Monoclonal Antibodies", Cancer Res. 44, 2052-61 (1984) (Exhibit 23).
Varki et al., "Antigens Associated with a Human Lung Adenocarcinoma Defined by Monoclonal Antibodies", Cancer Res. 44, 681-55 (1984) (Exhibit 24).
Embleton et al., "Antibody Targeting of Anti-Cancer Agents", Monoclonal Antibodies for Cancer Detection and Therapy, pp. 317-344 (1985) (Exhibit 25).
Domingo et al., "Transferrin Receptor as a Target for Antibody-Drug Conjugates", Meth. Enzymol. 112, 238-47 (1985) (Exhibit 26).
Kohler and Milstein, "Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity", Nature 256, 495-97 (1975) (Exhibit 27).
Oi et al., "Immunoglobulin Gene Expression in Transformed Lymphoid Cells", Proc. Natl. Acad. Sci. USA, 80:825 (1983) (Exhibit 28).
Potter et al., "Enhancer-dependent Expression of Human K Immunoglobulin Genes Introduced into Mouse Pre-B Lymphocytes by Electroporation", Proc. Natl. Acad. Sci. USA, 81:7161 (Exhibit 29).
Morrison et al., "Chimeric Human Antibody Molecules: Mouse Antigen-Binding Domains with Human Constant Region Domains", Proc. Natl. Acad. Sci. USA, 81:6581 (1984) (Exhibit 30).
Sahagan et al., "A Genetically Engineered Murine/Human Antibody Retains Specificity for Human Tumor-Associated Antigen", J. Immunol., 137:1066 (1986) (Exhibit 31).
Sun et al., "Chimeric Antibody with Human Constant Regions and Mouse Variable Regions Directed Against Carcinoma-Associated Antigen 17-1A", Proc. Natl. Acad. Sci., 84:214 (1987) (Exhibit 32).
Boulianne et al., "Production of Functional Chimaeric Mouse/Human Antibody", Nature, 312:643 (1984) (Exhibit 33).
Sharon et al., "Expression of a V.sub.H C.sub.K Chimeric Protein in Mouse Myeloma Cells", Nature, 309:364 (1984) (Exhibit 34).
Tan et al., "A Human-Mouse Chimeric Immunoglobulin Gene With a Human Variable Region is Expressed in Mouse Myeloma Cells", J. Immunol., 135:3564-3567 (1985) (Exhibit 35).
Folger et al., "Patterns of Integration of DNA Microinjected into Cultured Mammalian Cells: Evidence for Homologous Recombination Between Injected Plasmid DNA Molecules", Symp. Quant. Biol., 49:123-138 (1984) (Exhibit 36).
Folger et al., "Patterns of Integration of DNA Microinjected Into Cultured Mammalian Cells: Evidence for Homologous Recombination Between Injected Plasmid DNA Molecules", Mol. Cell Biol., 2:1372-1387 (1982) (Exhibit 37).
Kucherlapati, "Homologous Recombination Between Plasmids in Mammalian Cells Can Be Enhanced by Treatment of Input DNA", Proc. Natl. Acad. Sci. USA, 81:3153-3157 (1984) (Exhibit 38).
Lin et al., "Recombination in Mouse L Cells Between DNA Introduced Into Cells and Homologous Chromosomal Sequences", Proc. Natl. Acad. Sci. USA, 81:1391-1395 (1985) (Exhibit 39).
de Saint Vincent et al., "Homologous Recombination in Mammalian Cells Mediates Formation of a Functional Gene From Two Overlapping Gene Fragments", Proc. Natl. Acad. Sci. USA, 80:2002-2006 (1983) (Exhibit 40).
Shaul et al., "Homologous Recombination Between a Defective Virus and a Chromosomal Sequence in Mammalian Cells", Proc. Natl. Acad. Sci. USA, 82:3781-3784 (1985) (Exhibit 41).
Thomas et al., "High Frequency Targeting of Genes to Specific Sites in the Mammalian Genome", Cell, 44:419-428 (1986) (Exhibit 42).
Smithies et al., "Insertion of DNA Sequences Into the Human Chromosomal B-Globin Locus by Homologous Recombination", Nature, 317:230-234 (1985) (Exhibit 43).
Smith et al., "Homologous Recombination Between Defective Neo Genes in Mouse 3T6 Cells", Symp. Quant. Biol., 49:171-181 (1984) (Exhibit 44).
Song et al., "Accurate Modification of a Chromosomal Plasmid by Homologous Recombination in Human Cells", Proc. Natl. Acad. Sci. USA, 84:6820-6824 (1987) (Exhibit 45).
Rubinitz and Subramani, "Extrachromosomal and Chromosomal Gene Conversion in Mammalian Cells", Mol. Cell Biol., 6:1608-1614 (1986) (Exhibit 46).
Liskay, "Evidence for Intrachromosomal Gene Conversion in Cultured Mouse Cells", Cell, 35:157-165 (1983) (Exhibit 47).
Fell et al., "Homologous Recombination in Hybridoma Cells: Heavy Chain Chimeric Antibody Produced by Gene Targeting", Proc. Natl. Acad. Sci. USA, 86:8507-8511 (1989) (Exhibit 48).
Hellstrom et al., in "Covalently Modified Antigens and Antibodies in Diagnosis and Therapy", Quash & Rodwell, Eds., Marcel Dekkar, Inc., (Publ) (1988) (Exhibit 49).
Hellstrom et al., "Strong Antitumor Activities of IgG3 Antibodies to a Human Melanoma-Associated Ganglioside", Proc. Natl. Acad. Sci. USA, 82:1499-1502 (1985) (Exhibit 50).
Nudelman et al., "Characterization of a Human Melanoma-Associated Ganglioside Antigen Defined by a Monoclonal Antibody, 4.2", J. Biol. Chem., 257: (1); 12752-56 (1982) (Exhibit 51).
Hakamori, "Tumor-Associated Carbohydrate Antigens", Ann. Rev. Immunol., 2:103-26 (1984) (Exhibit 52).
Abe et al., "The Monoclonal Antibody Directed to Difucosylated Type 2 Chain (Fuc 1--2Gal 1--4 Fuc 1--3 GlycNAc; Y Determinant", J. Biol. Chem., 258:11793-97 (1983) (Exhibit 53).
Lloyd et al., "Mouse Monoclonal Antibody F-3 Recognizes the Difucosyl Type-2 Blood Group Structure", Immunogenetics, 17:537 (1988) (Exhibit 54).
Brown et al., "A Monoclonal Antibody Against Human Colonic Adenoma Recognizes Difucosylated Type-2-Blood-Group Chains", Biosci. Reports, 3:163 (1983) (Exhibit 55).
Hellstrom et al., "Monoclonal Mouse Antibodies Raised Against Human Lung Carcinoma", Cancer Res. 46, 3917-23 (1986) (Exhibit 56).
Abe et al., "Differential Expression of Difucosyl Type 2 Chain (Ley) Defined by Monoclonal Antibody AH6 in Different Locations of Colonic Epithelia, Various Histological Types of Colonic Polyps and Adenocarcinomas", Cancer Res., 46:2639-2644 (1986) (Exhibit 57).
Brown et al., "S
Glaser Scott
Huse William
Rosok Mae Joanne
Yelton Dale
Bristol--Myers Squibb Company
Feisee Lila
Ungar Susan
LandOfFree
Mutant BR96 antibodies reactive with human carcinomas does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutant BR96 antibodies reactive with human carcinomas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant BR96 antibodies reactive with human carcinomas will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-386459